Delivery Order SPE2DB22D3016-SPE2DB25FAHB3

Award Date 12/19/24
Potential Completion Date 12/20/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHB3
    Delivery Order

This is a delivery order under a Federal Supply Schedule (FSS) contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, with a ceiling value of $7,275.84 and a completion date of December 20, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a for-profit organization that specializes in distributing a wide range of pharmaceutical products, medical supplies, and equipment to federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of medical commodities to support military healthcare programs globally.

Generated 3/20/25, 10:43 AM